True North Metabolic
Advanced Lipid Assessment
A detailed cholesterol review beyond the basic panel, focused on overall cardiometabolic risk optimization. Includes interpretation and a clear treatment plan.
ApoB and Lipoprotein(a) Testing
Advanced markers that better reflect “atherogenic particle” burden and inherited risk. Useful when standard LDL doesn’t match the overall risk picture.
Familial Hypercholesteremia Genetic Testing
For eligible patients, we offer familial hypercholesterolemia genetic testing as well as treatment options.
Non-Statin Therapy
Personalized options when statins aren’t enough or aren’t tolerated. May include ezetimibe, bempedoic acid, omega-3 therapy, PCSK9 inhibitors or other targeted approaches.
Repatha & Leqvio Treatment
For patients who need deeper LDL reduction or can’t tolerate statins. We assess eligibility and build an evidence-based plan for advanced LDL-lowering therapy including treatment with options such as Repatha or Leqvio.
Triglyceride and Remnant Cholesterol Care
Focused treatment for high triglycerides and remnant cholesterol, which can increase cardiovascular and pancreatitis risk. Includes lifestyle strategy plus medication options when appropriate.